BlackRock Institutional Trust’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.7M | Buy |
132,975
+6,283
| +5% | +$80.1K | ﹤0.01% | 3113 |
|
|
2016
Q3 | $2.32M | Buy |
126,692
+73,039
| +136% | +$1.34M | ﹤0.01% | 2987 |
|
|
2016
Q2 | $569K | Sell |
53,653
-62,800
| -54% | -$666K | ﹤0.01% | 3460 |
|
|
2016
Q1 | $2.2M | Sell |
116,453
-1,655
| -1% | -$31.3K | ﹤0.01% | 2993 |
|
|
2015
Q4 | $3.14M | Buy |
118,108
+9,602
| +9% | +$255K | ﹤0.01% | 2919 |
|
|
2015
Q3 | $4.95M | Buy |
108,506
+35,758
| +49% | +$1.63M | ﹤0.01% | 2727 |
|
|
2015
Q2 | $2.34M | Sell |
72,748
-5,334
| -7% | -$172K | ﹤0.01% | 3052 |
|
|
2015
Q1 | $2.48M | Sell |
78,082
-742
| -0.9% | -$23.6K | ﹤0.01% | 3011 |
|
|
2014
Q4 | $2.98M | Sell |
78,824
-13,073
| -14% | -$494K | ﹤0.01% | 2938 |
|
|
2014
Q3 | $2.43M | Buy |
91,897
+760
| +0.8% | +$20.1K | ﹤0.01% | 2984 |
|
|
2014
Q2 | $2.7M | Buy |
91,137
+10,343
| +13% | +$306K | ﹤0.01% | 3046 |
|
|
2014
Q1 | $2.99M | Sell |
80,794
-218
| -0.3% | -$8.07K | ﹤0.01% | 2985 |
|
|
2013
Q4 | $3.35M | Sell |
81,012
-6,207
| -7% | -$257K | ﹤0.01% | 2951 |
|
|
2013
Q3 | $4.62M | Sell |
87,219
-21,459
| -20% | -$1.14M | ﹤0.01% | 2771 |
|
|
2013
Q2 | $5.8M | Buy |
+108,678
| New | +$5.8M | ﹤0.01% | 2616 |
|